News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
186 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17722)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
BioCapital
CEL-SCI Extends the Expiration Date of Series DD and Series EE Warrants Issued in December 2016 - Nov. 28, 2017
Following the Company’s reverse split in June 2017, twenty-five (25) Series DD and Series EE warrants will be required to purchase one share at an exercise price of $4.50.
November 28, 2017
·
1 min read
BioMidwest
Importance of Quantitative Analysis in Breast Imaging Highlighted in Clinical and Research Results Presented at RSNA
Four abstracts highlighted the use of Volpara’s quantitative analysis tools for breast imaging.
November 28, 2017
·
4 min read
Drug Development
Merck KGaA, Pfizer’s Bavencio Flunks Late-Stage Gastric Cancer Trial
The safety profile of avelumab was consistent with that observed in the overall JAVELIN clinical development program.
November 28, 2017
·
12 min read
Biotech Bay
Omnicell Introduces Revolutionary New Solution to Automate Critical Workflows in Central Pharmacy
The Omnicell XR2 Automated Central Pharmacy System, designed with input from leading health system pharmacies, streamlines critical workflows to maximize inventory control, improve operational efficiency, and increase medication safety.
November 28, 2017
·
3 min read
BioMidwest
Medizone to Meet With FDA Regarding the AsepticSure Disinfection System, a Revolutionary Disinfection Technology
Medizone today announced that it will meet with representatives of the FDA on January 18, 2018 to discuss the planned submission of a marketing application for AsepticSure.
November 28, 2017
·
2 min read
Biotech Beach
Biocept and UC San Diego Medical Center Announce Clinical Study Collaboration to Demonstrate Utility of Biocept’s Liquid Biopsy Test in Immunotherapy
The 100-patient study is designed to clinically validate Biocept’s Target Selector PD-L1 assay for patients diagnosed with NSCLC.
November 28, 2017
·
5 min read
Business
Champions Oncology to Announce Second Quarter Financial Results on Thursday, December 7, 2017
The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST).
November 28, 2017
·
1 min read
Business
Charles River Announces Success of Integrated Discovery Project With ENYO Pharma
ENYO Pharma worked with scientists from Charles River to optimize a potent, novel chemical series (with unknown molecular target) for inhibition of Influenza replication.
November 28, 2017
·
4 min read
Business
Ironwood Appoints New COO and CFO
The company announced the appointment of William Huyett as COO and the promotion of Gina Consylman to senior vice president and CFO.
November 28, 2017
·
6 min read
Policy
PAVmed Files 510(k) Submission With FDA for CarpX Device to Treat Carpal Tunnel Syndrome
Designed to replace invasive surgery and shorten recovery time; addresses an estimated $1 billion market opportunity.
November 28, 2017
·
6 min read
Previous
7 of 19
Next